Lanean...
Improving Post-Approval Drug Safety Surveillance: Getting Better Information Sooner
Adverse drug events (ADEs) are an important public health concern, accounting for 5% of all hospital admissions and two-thirds of all complications occurring shortly after hospital discharge. There are often long delays between when a drug is approved and when serious ADEs are identified. Recent and...
Gorde:
| Argitaratua izan da: | Annu Rev Pharmacol Toxicol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677571/ https://ncbi.nlm.nih.gov/pubmed/25292435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-pharmtox-011613-135955 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|